Needham & Company
-
K2M Group Holdings (KTWO) PT Lowered to $26 at Needham & Company Following 3Q Release
-
K2M Warning is a Negative Read-Through for Globus Medical (GMED) and NuVasive (NUVA) - Needham & Company
-
K2M Group Holdings (KTWO) PT Lowered to $27 at Needham & Company; Keeps Top Rating
-
K2M Group Holdings, Inc. to Present at the 16th Annual Needham Healthcare Conference
-
Needham & Company Reiterates Strong Buy and $29 PT on K2M Group Holdings (KTWO) Following 4Q Results
-
K2M Group (KTWO): Raising PT After Preannouncement - Needham
-
Needham & Company Raises Price Target on K2M Group (KTWO) to $25; Reiterates Strong Buy
-
Needham & Company Raises Price Target on K2M Group (KTWO) Following 2Q Beat
-
ResMed (RMD), St. Jude (STJ), Cepheid (CPHD) Among Med Tech Companies with Most EU Exposure - Needham & Company
-
Needham & Company Upgrades K2M Group Holdings (KTWO) to Strong Buy
-
K2M Group Holdings, Inc. to Present at the 15th Annual Needham Healthcare Conference
-
K2M Group (KTWO) Growth Driven by New products and Expanding Distribution; Needham & Company Cuts Price Target to $25
-
Needham & Company Starts K2M Group Holdings (KTWO) at Buy

